Photograph of Chalana N. Damron Download V-card

Chalana N. Damron

Phone: +1 202.624.2566
1001 Pennsylvania Avenue NW
Washington, DC 20004-2595

Selected for the 2019
Pathfinder Program
of the Leadership Council
on Legal Diversity

Chalana N. Damron is a counsel in the firm's Mass Tort, Product, and Consumer Litigation Group. Chalana’s litigation practice spans numerous industries including aviation, healthcare, pharmaceutical, and food & beverage. She represents clients in a diverse array of litigations, including commercial, antitrust, class action, and product liability.

Representative Litigation Matters

  • Representing pharmaceutical distributor in product liability litigation filed in multiple jurisdictions, both state and federal, stemming from voluntary recall.
  • Representing major domestic airline in a federal antitrust class action.
  • Represented leading snack food manufacturer in defense of breach of contract and promissory estoppel claims in Illinois federal court, obtaining summary judgment on all claims prior to trial.
  • Represented parts supplier in litigation over alleged product defect and warranty claims.
  • Represented personal care company in false advertising litigation under the Lanham Act.
Recognizing the intersection between regulatory compliance and litigation vulnerability, Chalana also leverages her litigation experience when advising FDA-regulated companies on a variety of regulatory, enforcement, and compliance matters. As part of her regulatory practice, Chalana assists clients with preparing for FDA inspections, evaluating quality systems, responding to FDA 483 observations, and becoming compliant with the Federal Food , Drug and Cosmetic Act. She regularly evaluates and offers commentary on litigation and regulatory developments impacting FDA-regulated industries, and provides clients with mechanisms to limit the risk of marketing-related challenges by plaintiffs and regulators. Additionally, Chalana develops and conducts comprehensive training programs to assist regulatory executives and marketing teams with understanding and complying with FDA regulations. 

In response to COVID-19, Chalana has leveraged her litigation and FDA experience to guide companies as they pivot their businesses to mitigate critical supply shortages throughout the country. Chalana also assists companies with navigating the myriad of federal and state regulations aimed at reducing the spread of COVID-19 and counsels clients on COVID-19 litigation strategies and defenses.

Chalana is an active participant in Crowell and Moring's pro bono program and focuses on housing issues, such as housing discrimination and landlord-tenant disputes. She has represented plaintiffs in two fair housing cases brought in the Eastern District of Virginia.
Chalana received her J.D. from the University of Virginia School of Law where she was a member of the Black Law Student Association's Trial Advocacy Team. She earned a B.S. in political science, summa cum laude, from Christopher Newport University.


  • Christopher Newport University, B.S. political science (2009) summa cum laude
  • University of Virginia School of Law, J.D. (2013)


Admitted to practice: District of Columbia, Virginia, U.S. District Court for the Eastern District of Virginia

View More

"Milton C. Grimes: A Lifetime of Fighting Against Injustice," Orange County Bar Association, (April 15, 2021). Webinar Co-Speaker: Chalana N. Damron
"Understanding the Scope of FDA Enforcement Authority and Actions," 36th Annual FDA Boot Camp (March 25, 2021). Speaker: Chalana N. Damron.
Crowell & Moring Lawyers Engage with Corporate Officers at National Bar Association Commercial Law Section’s Annual Corporate Counsel Conference (Mar.05.2021)
Firm News / Announcement
"Fireside Chat" with Wendy Web Williams, Sara Lee Frozen Bakery, NBA-CLS 34th Annual Corporate Counsel Conference (February 25, 2021). Moderator: Chalana N. Damron.
"FDA and the Response to COVID: Lessons Learned, and Where the Agency Goes From Here," Healthcare Ounce of Prevention Seminar (HOOPS) 2021: Health Care in the Biden Era (February 23, 2021). Presenters: John Fuson, Chalana N. Damron, and Nicholas J. Diamond.
"GAO Calls on FDA to Prepare to Resume Inspections of Drug Manufacturers," Mass Tort, Product, and Consumer Litigation Alert (February 9, 2021). Contacts: John Fuson, Chalana N. Damron, Eryn Howington
Client Alert / Newsletter
Navigating New Waves Of Tortious Litigation Lawyers Weekly (January 19, 2021)
Media Mentions
What In-House Counsel Should Know About New COVID-19 Litigation Corporate Counsel (January 14, 2021)
Media Mentions
"New Litigation Frontiers, Brought to You by COVID," Crowell & Moring's Litigation Forecast 2021 (January 13, 2021). Contributors: Allyson McKinstry, Luke van Houwelingen, and Chalana Damron
"PREP Act Protections For COVID-19 Vaccine Liability," Pharmaceutical Executive (January 11, 2021). Authors: Cheryl A. Falvey, Chalana N. Damron, Hilary Johnson, Mariam Sarwar.

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with approximately 550 lawyers representing clients in litigation and arbitration, regulatory and policy, and transactional matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation, as well as its ongoing commitment to pro bono service and diversity, equity and inclusion. The firm has offices in Brussels, Doha, London, Los Angeles, New York, Orange County, San Francisco, Shanghai, and Washington, D.C.

View Desktop Site | Mobile Sitemap |

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2021
Attorney advertising - prior results do not guarantee a similar outcome.